Latest profit margin for DaVita: 5.65% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
The latest profit margin for DVA is 5.65% as of March 2026. That compares with 6.63% in the prior-year period — down 14.8% year over year. That is below the Healthcare sector average of 15.52%. Investors often review this figure alongside DaVita's historical trend and sector peers before judging valuation or financial health.
Over the past year, DVA's profit margin moved from 6.63% to 5.65% — a 14.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in DaVita's valuation or profitability profile.
Against Healthcare companies, DVA currently prints 5.65% for profit margin, while the sector average sits near 15.52%. That is roughly 63.6% below the sector mean. Large gaps often invite a closer look at DaVita's growth, margins, and balance sheet.
Profit Margin shows how effectively DaVita converts resources into returns. At 5.65%, DVA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 6.63% in the prior-year period — down 14.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting DVA's profit margin (5.65%), review year-over-year change from 6.63%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.